Emergent BioSolutions Inc.EBSNYSE
Loading
Price to free cash flow ratio
5Y CAGR
-18.8%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.22 | -70.2% |
| 2024 | 14.15 | +3070.4% |
| 2023 | -0.48 | +87.9% |
| 2022 | -3.95 | -116.3% |
| 2021 | 24.20 | +102.4% |
| 2020 | 11.95 | -56.5% |
| 2019 | 27.48 | +128.0% |
| 2018 | -98.02 | -873.3% |
| 2017 | 12.67 | +121.9% |
| 2016 | -57.96 | - |